7112US Cenp-B (FDA cleared)
Intended Use:
AESKULISA Cenp-B is a solid phase enzyme immunoassay for the quantitative and qualitative detection of IgG antibodies against Cenp-B in human serum.
Recombinant Antigens:
80 kDa Cenp-B
Native Antigens:
n.a.
Published in
Rheumatology (FDA cleared Products)
Tagged under